美股詳情

本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

施貴寶

48.53

-1.2900-2.59%

盤後：48.44-0.0900-0.19%17:44 EDT

成交量：2,402.99萬

成交額：11.63億

市值：987.47億

市盈率：-10.99

高：49.33

開：47.63

低：47.54

收：49.82

資料載入中...

總覽公司新聞公告

商務部部長王文濤會見百時美施貴寶董事會主席兼首席執行官博科思

王文濤部長會見百時美施貴寶董事會主席兼首席執行官博科思

延長肝癌患者生命！百時美施貴寶(BMY.US)一線免疫組合療法獲歐盟批准

施貴寶(BMY)漲近3% 公司一款肝癌療法獲歐盟批准

百時美施貴寶肝癌藥物獲得歐盟批准

环球市场播报

棄了！百時美施貴寶終止KRAS G12D項目

市場動盪，3支防禦性股票技術上穩固

施貴寶盤中異動股價大漲3.01%

緩解率超70%！百時美施貴寶(BMY.US)突破性免疫組合療法獲FDA優先審評資格

嗡嗡聲--美國股票走勢-星巴克、百時美施貴寶、家得寶

BUZZ-FDA 接受治療結直腸癌的組合藥物申請後，百時美施貴寶公司股價上漲

百時美施貴寶稱FDA已接受其結直腸癌藥物申請

环球市场播报

摩根大通頂級生物醫藥股精選：點名三隻潛力股，禮來仍是首選

老虎资讯综合

百時美施貴寶重磅免疫療法組合顯著延長肺癌患者生命

百時美施貴寶下跌3.03%，報54.275美元/股

百時美施貴寶PD-1+LAG-3組合療法一項III期研究失敗

医药魔方Info

施貴寶2024財年實現淨利潤-89.48億美元，同比減少211.50%

百時美施貴寶上漲1.22%，報56.205美元/股

百時美施貴寶稱淋巴瘤藥物2期試驗數據積極

环球市场播报

百時美施貴寶2024年營收同比增長7% 預計今年成熟產品收入至少下降18%

每日经济新闻

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/BMY/news?page=3"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BMY","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BMY\",,,,,undefined,":{"symbol":"BMY","market":"US","secType":"STK","nameCN":"施貴寶","latestPrice":48.53,"timestamp":1745438400000,"preClose":49.82,"halted":0,"volume":24029857,"hourTrading":{"tag":"盘后","latestPrice":48.44,"preClose":48.53,"latestTime":"17:44 EDT","volume":402866,"amount":19550833.17442,"timestamp":1745444693266},"delay":0,"floatShares":2030829795,"shares":2034763196,"eps":-4.414405,"marketStatus":"盤後交易","change":-1.29,"latestTime":"04-23 17:44:59 EDT","open":47.63,"high":49.33,"low":47.54,"amount":1162646087.0543718,"amplitude":0.035929,"askPrice":48.91,"askSize":1000,"bidPrice":48.43,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-4.414405,"tradingStatus":3,"nextMarketStatus":{"tag":"收盤","tradingStatus":0,"beginTime":1745452800000},"marketStatusCode":4,"adr":0,"adrRate":0,"listingDate":-18475200000,"exchange":"NYSE","adjPreClose":49.82,"dividendRate":0.049866,"preHourTrading":{"tag":"盘前","latestPrice":47.87,"preClose":49.82,"latestTime":"09:29 EDT","volume":289474,"amount":13746248.364311999,"timestamp":1745414999981},"postHourTrading":{"tag":"盘后","latestPrice":48.44,"preClose":48.53,"latestTime":"17:44 EDT","volume":402866,"amount":19550833.17442,"timestamp":1745444693266},"volumeRatio":1.750563,"optionData":{"bulkOrders":[{"symbol":"BMY","call":false,"expireDate":1746158400000,"strike":"48.5","timestamp":1745433166567,"price":1.64,"volume":2000,"amount":328000,"type":"-"}]},"impliedVol":0.4254,"impliedVolPercentile":0.928},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BMY\",,,,,undefined,":{"symbol":"BMY","floatShares":2030829795,"roa":"6.55%","roe":"-38.95%","lyrEps":-4.414405,"volumeRatio":1.750563,"shares":2034763196,"dividePrice":2.42,"high":49.33,"amplitude":0.035929,"preClose":49.82,"low":47.54,"week52Low":39.35,"pbRate":"6.05","psRate":"2.04","week52High":63.33,"institutionHeld":0.6798,"latestPrice":48.53,"committee":-0.818182,"eps":-4.414405,"divideRate":0.049866,"volume":24029857,"delay":0,"ttmEps":-4.414405,"open":47.63,"prevYearClose":56.56,"prevWeekClose":49.23,"prevMonthClose":60.99,"prevQuarterClose":60.99,"fiveDayClose":50,"twentyDayClose":59.19,"sixtyDayClose":60.6},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BMY\",pageSize:20,pageCount:3,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2518222504","title":"商務部部長王文濤會見百時美施貴寶董事會主席兼首席執行官博科思","url":"https://stock-news.laohu8.com/highlight/detail?id=2518222504","media":"界面","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518222504?lang=zh_tw&edition=fundamental","pubTime":"2025-03-10 20:40","pubTimestamp":1741610458,"startTime":"0","endTime":"0","summary":"3月10日，商务部部长王文涛会见百时美施贵宝公司董事会主席兼首席执行官博科思。双方就百时美施贵宝公司对华合作情况、中美经贸关系等议题进行了交流。王文涛表示，面对复杂严峻的国际形势，中国经济运行总体平稳、稳中有进，仍是世界经济增长的重要引擎和稳定力量。当前，中国医药行业进入高质量发展新阶段，希望以百时美施贵宝为代表的生物制药行业企业向中国市场引进更多先进产品和服务，参与健康中国建设，共享中国发展机遇。王文涛指出，贸易战没有赢家，保护主义没有出路，中美两国在互利共赢基础上开展经贸合作，为两国业界正常经贸合作创造稳定环境，符合两国人民共同利益。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310204058a26a1299&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310204058a26a1299&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0321505439.SGD","LU1291159041.SGD","LU2360032135.SGD","BK4532","LU1670711040.USD","LU0114720955.EUR","LU1989771016.USD","LU0096364046.USD","IE00BJT1NW94.SGD","LU1074936037.SGD","LU1868837136.USD","LU1868836914.USD","LU1571399168.USD","LU1670711123.USD","BK4588","IE00BFXG1179.USD","LU2133065610.SGD","LU0321505868.SGD","LU1093756168.USD","BK4581","LU2242646821.SGD","BK4007","LU1868836757.USD","LU0225284248.USD","LU1670710588.SGD","LU1670710661.SGD","LU1261432733.SGD","LU0882574055.USD","LU2125154778.USD","LU0237698245.USD","BK4585","LU0225771236.USD","LU0306807586.USD","BMY","LU0061475181.USD","LU2242652126.USD","LU0456855351.SGD","LU2125154935.USD","LU1868836591.USD","LU1430594728.SGD","LU0985481810.HKD","LU0868494617.USD","IE0002141913.USD","LU1032466523.USD","LU1585245621.USD","LU1718418525.SGD","BRCD","LU1868837300.USD","IE00BJJMRZ35.SGD","IE00BSNM7G36.USD"],"gpt_icon":0},{"id":"2518226327","title":"王文濤部長會見百時美施貴寶董事會主席兼首席執行官博科思","url":"https://stock-news.laohu8.com/highlight/detail?id=2518226327","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518226327?lang=zh_tw&edition=fundamental","pubTime":"2025-03-10 20:39","pubTimestamp":1741610361,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["600056","LU0061475181.USD","BK0185","LU0225771236.USD","LU0985481810.HKD","IE0002141913.USD","LU1868837136.USD","LU0114720955.EUR","BK4007","LU2242646821.SGD","BK0082","BK4588","YINN","LU0306807586.USD","LU1074936037.SGD","IE00B2B36J28.USD","BK0175","LU0321505439.SGD","BK0010","LU1868836757.USD","BRCD","LU1430594728.SGD","LU1718418525.SGD","BK0028","BK0250","LU1093756168.USD","LU1670711123.USD","IE00BJT1NW94.SGD","IE00BSNM7G36.USD","IE0009355771.USD","LU1670710661.SGD","BK4532","BK0188","LU0868494617.USD","LU2133065610.SGD","LU1032466523.USD","LU1989771016.USD","BK4534","LU2242652126.USD","BK4581","LU0456855351.SGD","BMY","LU1571399168.USD","IE00BFXG1179.USD","LU1261432733.SGD","LU1868836914.USD","LU0225284248.USD","LU0306806265.USD","IE00BJJMRZ35.SGD","LU0237698245.USD"],"gpt_icon":0},{"id":"2518206204","title":"延長肝癌患者生命！百時美施貴寶(BMY.US)一線免疫組合療法獲歐盟批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2518206204","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518206204?lang=zh_tw&edition=fundamental","pubTime":"2025-03-09 07:50","pubTimestamp":1741477805,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，百时美施贵宝宣布，欧盟委员会已批准其重磅PD-1抑制剂Opdivo与CTLA-4靶向抗体Yervoy联用，一线治疗不可切除或晚期肝细胞癌成人患者。据悉，美国FDA已接受Opdivo联合Yervoy治疗同一患者群体的补充生物制品许可申请，预计在今年4月21日之前完成审评。公开资料显示，Opdivo是一种PD-1免疫检查点抑制剂，旨在帮助恢复抗肿瘤免疫反应，利用人体自身的免疫系统来对抗癌症。数据显示，Opdivo联合Yervoy治疗显著延长患者的总生存期，达到试验的主要临床终点。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1259429.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":"延长肝癌患者生命！百时美施贵宝(BMY.US)一线免疫组合疗法获欧盟批准","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU1430594728.SGD","LU1868836757.USD","LU1585245621.USD","LU2133065610.SGD","LU1868836591.USD","BK4588","LU0868494617.USD","LU2242652126.USD","LU1670710588.SGD","LU1868837136.USD","LU0306806265.USD","BK4532","BK4581","IE00BSNM7G36.USD","LU0321505868.SGD","IE00BFXG1179.USD","LU0225284248.USD","LU2242646821.SGD","LU1323610961.USD","IE00BJJMRZ35.SGD","IE00B2B36J28.USD","IE00BFTCPJ56.SGD","BMY","LU0114720955.EUR","LU0306807586.USD","LU1571399168.USD","BK4585","LU1032466523.USD","LU1989771016.USD","LU1291159041.SGD","LU0321505439.SGD","BK4007","LU0225771236.USD","LU1670710661.SGD","IE0002141913.USD","LU2125154935.USD","LU0456855351.SGD","LU0096364046.USD","BK4559","LU1868836914.USD","LU1261432733.SGD","LU0061475181.USD","LU1670711040.USD","LU0237698245.USD","LU1868837300.USD","LU1093756325.SGD","LU1093756168.USD","LU0882574055.USD","LU2360032135.SGD","LU1074936037.SGD"],"gpt_icon":0},{"id":"2517431600","title":"施貴寶(BMY)漲近3% 公司一款肝癌療法獲歐盟批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2517431600","media":"金吾财讯","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517431600?lang=zh_tw&edition=fundamental","pubTime":"2025-03-07 22:59","pubTimestamp":1741359598,"startTime":"0","endTime":"0","summary":"金吾财讯 | 制药巨头百时美施贵宝（Bristol Myers Squibb，BMY）股价走高，截至发稿，涨2.97%，报61.97美元，成交额1.08亿美元。施贵宝宣布其开发的一款肝癌疗法已获得欧盟委员会批准。该公司称，其Opdivo和Yervoy联合疗法作为成年晚期肝癌患者的一线治疗方案，特别针对不可切除或晚期肝细胞癌，已获欧盟批准，这标志着欧盟及其相关国家在该类型癌症治疗选择方面取得重大进展。","market":"fut","thumbnail":"https://static.szfiu.com/news/20250107/MzZmY2I0ODMyNDljNDZhYjk1YmMwYzA2ZTYzZmI3NWMyMTczNjIzMDYxMjY4Mg==.png","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250107/MzZmY2I0ODMyNDljNDZhYjk1YmMwYzA2ZTYzZmI3NWMyMTczNjIzMDYxMjY4Mg==.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"286192","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BJJMRZ35.SGD","IE00BJT1NW94.SGD","LU1032466523.USD","LU0225284248.USD","LU2133065610.SGD","LU0456855351.SGD","IE00BFXG1179.USD","LU1989771016.USD","LU2125154778.USD","IE00BFTCPJ56.SGD","IE0009355771.USD","BK4532","LU2242652126.USD","LU1868836914.USD","LU1261432733.SGD","LU1718418525.SGD","IE0002141913.USD","LU0306807586.USD","LU1093756168.USD","LU1291159041.SGD","LU0061475181.USD","LU1093756325.SGD","BK4007","LU1670710661.SGD","LU1585245621.USD","LU0114720955.EUR","LU0306806265.USD","LU1868837300.USD","IE00B2B36J28.USD","BK4534","LU1430594728.SGD","LU1868836591.USD","LU0868494617.USD","LU1670710588.SGD","IE00BSNM7G36.USD","LU0321505439.SGD","LU0321505868.SGD","LU1868836757.USD","LU2242646821.SGD","LU2125154935.USD","LU2360032135.SGD","BMY","LU1074936037.SGD","BK4585","LU0225771236.USD","BK4588","LU0985481810.HKD","LU0237698245.USD","LU0882574055.USD","LU0096364046.USD"],"gpt_icon":0},{"id":"2517343196","title":"百時美施貴寶肝癌藥物獲得歐盟批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2517343196","media":"环球市场播报","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517343196?lang=zh_tw&edition=fundamental","pubTime":"2025-03-07 22:52","pubTimestamp":1741359120,"startTime":"0","endTime":"0","summary":"制药巨头百时美施贵宝（Bristol Myers Squibb）宣布其开发的一款肝癌疗法已获得欧盟委员会批准。\n　　该公司称，其Opdivo和Yervoy联合疗法作为成年晚期肝癌患者的一线治疗方案，特别针对不可切除或晚期肝细胞癌，已获欧盟批准，这标志着欧盟及其相关国家在该类型癌症治疗选择方面取得重大进展。\n\n\n\n海量资讯、精准解读，尽在新浪财经APP\n\n责任编辑：张俊 SF065","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/usstock/c/2025-03-07/doc-inenwaua9553772.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["LU0096364046.USD","IE00BFTCPJ56.SGD","LU1670711123.USD","LU1585245621.USD","IE00B2B36J28.USD","LU1093756168.USD","BK4581","LU1323610961.USD","LU0456855351.SGD","BK4588","LU1868836591.USD","LU1670711040.USD","LU1093756325.SGD","LU2125154935.USD","LU0306806265.USD","LU2360032135.SGD","IE0002141913.USD","LU1430594728.SGD","LU1868836914.USD","LU0321505439.SGD","BK4007","LU0868494617.USD","LU1670710661.SGD","BK4585","IE00BSNM7G36.USD","IE0009355771.USD","LU1989771016.USD","LU1291159041.SGD","IE00BJJMRZ35.SGD","LU1032466523.USD","LU1868837300.USD","LU0985481810.HKD","LU2125154778.USD","LU0114720955.EUR","LU1868837136.USD","LU0237698245.USD","LU1718418525.SGD","LU2133065610.SGD","BK4559","LU0321505868.SGD","BK4532","BMY","LU1074936037.SGD","LU2242646821.SGD","LU0061475181.USD","LU0306807586.USD","LU0882574055.USD","LU1670710588.SGD","IE00BFXG1179.USD","LU0225284248.USD"],"gpt_icon":0},{"id":"2517124356","title":"棄了！百時美施貴寶終止KRAS G12D項目","url":"https://stock-news.laohu8.com/highlight/detail?id=2517124356","media":"新浪财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517124356?lang=zh_tw&edition=fundamental","pubTime":"2025-03-07 13:16","pubTimestamp":1741324577,"startTime":"0","endTime":"0","summary":"2025年3月5日，据外媒消息， 百时美施贵宝 已放弃了此前收购的KRAS G12D抑制剂MRTX1133项目。寄予厚望的KRAS项目此前被百时美施贵宝看中的MRTX1133，就是一种有效的、选择性的和非共价的KRAS G12D抑制剂，目前处于I期临床阶段。试验数据“泼冷水”此次，放弃KRAS G12D抑制剂MRTX1133研发项目。这些负面消息让BMS对同为KRAS靶点的G12D项目未来的市场竞争力和商业前景深感担忧。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250307132834abec709a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250307132834abec709a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0321505868.SGD","BMY","LU1670711040.USD","BK4581","LU0225771236.USD","LU1989771016.USD","LU0114720955.EUR","LU1868837300.USD","LU2133065610.SGD","LU0225284248.USD","LU0237698245.USD","IE00BJT1NW94.SGD","LU1074936037.SGD","BK4559","LU1032466523.USD","LU1868836757.USD","LU0321505439.SGD","LU1291159041.SGD","BK4532","LU0306807586.USD","LU1670711123.USD","IE00B2B36J28.USD","LU1430594728.SGD","LU2125154935.USD","LU0456855351.SGD","LU1093756325.SGD","BK4585","LU1670710588.SGD","IE0002141913.USD","LU0985481810.HKD","LU1670710661.SGD","IE00BSNM7G36.USD","LU0882574055.USD","BK4534","LU1571399168.USD","LU0061475181.USD","LU0868494617.USD","LU2242646821.SGD","IE00BJJMRZ35.SGD","LU2125154778.USD","BK4007","BK4588","LU1868836591.USD","LU1868837136.USD","LU0096364046.USD","IE0009355771.USD","LU1585245621.USD","LU1868836914.USD","IE00BFTCPJ56.SGD","LU1261432733.SGD"],"gpt_icon":0},{"id":"2517979336","title":"市場動盪，3支防禦性股票技術上穩固","url":"https://stock-news.laohu8.com/highlight/detail?id=2517979336","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517979336?lang=zh_tw&edition=fundamental","pubTime":"2025-03-06 08:13","pubTimestamp":1741219980,"startTime":"0","endTime":"0","summary":"本文将重点介绍三只具有共同特征的股票：它们来自在熊市阶段表现较好的防御性行业，其股息收益率高于S&P 500，并且技术形态具有吸引力。BTI在1月中旬跳空上涨，创下52周新高，并在上月突破42美元，但在季度财报公布后出现跳空回落。财报不及预期使BTI股价下跌约13%，回落至50日移动均线，而该均线再次发挥关键支撑作用。当前，AEP站上两条上升趋势的移动均线，价格动能增强，相对强势提高，且股息收益率约为3.4%。","market":"us","thumbnail":"http://imgcloud.jrjimg.cn/2025/03/weixin/one_20250306081320258.webp","type":0,"news_type":0,"thumbnails":["http://imgcloud.jrjimg.cn/2025/03/weixin/one_20250306081320258.webp"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://usstock.jrj.com.cn/2025/03/06081348552984.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_highlight","symbols":["IE00B7SZLL34.SGD","SH","LU1670710588.SGD","LU0985481810.HKD","ESmain","BK4581","BK4075","IE00BSNM7G36.USD","LU1032466523.USD","LU2242652126.USD","LU1093756325.SGD","SPY","SSO","BK4606","LU1718418525.SGD","OEF","IE00BFTCPJ56.SGD","LU0306807586.USD","LU1894683348.USD","LU1868836591.USD","LU0306806265.USD","LU1291159041.SGD","BK4585","SPXU","LU1074936037.SGD","BK4081","SDS","UPRO","BK4559","LU0882574055.USD","IVV","VOO","LU1868837136.USD","LU0321505868.SGD",".SPX","LU1093756168.USD","AEP","LU1989771016.USD","LU0868494617.USD","BTI","BMY","LU0061475181.USD","LU1585245621.USD","LU2125154935.USD","LU2360032135.SGD","IE00B19Z3581.USD","LU0456855351.SGD","OEX","IE0009355771.USD","LU2125154778.USD"],"gpt_icon":0},{"id":"2514018286","title":"施貴寶盤中異動 股價大漲3.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514018286","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514018286?lang=zh_tw&edition=fundamental","pubTime":"2025-02-25 22:48","pubTimestamp":1740494939,"startTime":"0","endTime":"0","summary":"北京时间2025年02月25日22时48分，施贵宝股票出现波动，股价急速拉升3.01%。截至发稿，该股报59.62美元/股，成交量135.128万股，换手率0.07%，振幅2.26%。施贵宝股票所在的制药行业中，整体涨幅为2.03%。百时美施贵宝的一个重点是免疫肿瘤学，该公司在药物开发方面处于领先地位。百时美施贵宝近70%的总销售额来自美国，显示出对美国市场的依赖程度高于大多数同行。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225224859962ff6b6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225224859962ff6b6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1032466523.USD","LU1074936037.SGD","LU1718418525.SGD","LU2125154935.USD","IE0002141913.USD","LU0114720955.EUR","IE00B2B36J28.USD","LU1868837136.USD","BMY","LU1989771016.USD","LU2125154778.USD","LU2242652126.USD","LU0321505439.SGD","BK4534","LU2360032135.SGD","IE00BSNM7G36.USD","LU0321505868.SGD","LU2133065610.SGD","LU1093756325.SGD","LU1670711040.USD","LU0061475181.USD","LU1868836757.USD","IE00BFTCPJ56.SGD","LU0882574055.USD","LU0306806265.USD","LU1670710588.SGD","BK4532","IE00BJT1NW94.SGD","IE0009355771.USD","BK4007","LU1430594728.SGD","BK4559","LU1670710661.SGD","LU0868494617.USD","BK4588","LU1868836914.USD","LU1291159041.SGD","BK4585","LU2242646821.SGD","LU1571399168.USD","LU1585245621.USD","LU1093756168.USD","LU0456855351.SGD","LU1323610961.USD","IE00BJJMRZ35.SGD","LU1670711123.USD","LU1868837300.USD","LU1261432733.SGD","LU0985481810.HKD","LU1868836591.USD"],"gpt_icon":0},{"id":"2514030317","title":"緩解率超70%！百時美施貴寶(BMY.US)突破性免疫組合療法獲FDA優先審評資格","url":"https://stock-news.laohu8.com/highlight/detail?id=2514030317","media":"智通财经","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514030317?lang=zh_tw&edition=fundamental","pubTime":"2025-02-25 14:26","pubTimestamp":1740464796,"startTime":"0","endTime":"0","summary":"FDA已授予该申请突破性疗法认定和优先审评资格，预计在2025年6月23日之前完成审评。在今年1月底公布的分析结果显示，在中位随访时间为47个月时，接受Opdivo联合Yervoy治疗的患者，与Opdivo单药疗法相比，疾病进展或死亡风险降低38%。在12、24和36个月时，Opdivo联合Yervoy的无进展生存率分别为76%、71%和68%，均高于Opdivo单药疗法的63%、56%和51%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1253909.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"缓解率超70%！百时美施贵宝(BMY.US)突破性免疫组合疗法获FDA优先审评资格","news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU2125154778.USD","LU0061475181.USD","LU0225771236.USD","LU1670711040.USD","LU0985481810.HKD","LU1868837136.USD","LU2125154935.USD","LU0114720955.EUR","LU2360032135.SGD","BK4007","LU0321505868.SGD","LU2242646821.SGD","BK4588","LU0306807586.USD","LU1074936037.SGD","LU1585245621.USD","IE00B2B36J28.USD","LU0321505439.SGD","LU1291159041.SGD","LU1718418525.SGD","BK4585","LU1430594728.SGD","LU1093756325.SGD","LU1093756168.USD","LU1670710588.SGD","LU1323610961.USD","IE00BJT1NW94.SGD","BK4559","IE00BSNM7G36.USD","IE0009355771.USD","LU0096364046.USD","IE00BFTCPJ56.SGD","BK4532","LU0868494617.USD","LU1868837300.USD","LU2133065610.SGD","LU1032466523.USD","LU1989771016.USD","BK4534","BK4581","LU0456855351.SGD","BMY","LU1571399168.USD","LU0882574055.USD","LU1868836914.USD","LU0225284248.USD","LU0306806265.USD","IE00BJJMRZ35.SGD","LU1868836591.USD","LU0237698245.USD"],"gpt_icon":0},{"id":"2514777872","title":"嗡嗡聲--美國股票走勢-星巴克、百時美施貴寶、家得寶","url":"https://stock-news.laohu8.com/highlight/detail?id=2514777872","media":"路透中文","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514777872?lang=zh_tw&edition=fundamental","pubTime":"2025-02-25 02:51","pubTimestamp":1740423080,"startTime":"0","endTime":"0","summary":".N 美东时间13:30，道琼斯工业平均指数.DJI上涨0.52%，报43,653.47点。标准普尔500指数.SPX上涨0.25%，报6028.09点；纳斯达克综合指数.IXIC下跌0.13%，报19497.88点。标准普尔500指数.PG.INX百分比涨幅前三名：** 耐克公司NKE.N，上涨5.0%** Live Nation娱乐公司LYV.N，上涨4.9%** 伯克希尔哈撒韦公司BRKb.N，上涨4.7. BUZZ--在Guggenheim将其评级提升至 \"买入 \"后上涨，因其销售有可能重新加速 nL3N3PF0QG. BUZZ - 因第四季度业绩 \"积极 \"而上涨 nL2N3PF0KY ** BioCryst Pharmaceuticals Inc BCRX.O:BUZZ - 因季度亏损幅度超过预期而下跌 nL3N3PF","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250224:nL3S3PF1C9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NEXT","BMRN","SMMT","GFI","BRDG","LU2552382215.SGD","LU2125154935.USD","SBUX","RCL","CCL","BBWI","YYAI","SUI","BBNX","WING","LU2403377893.USD","TRDA","PODD","IE00B3SWFQ91.USD","FDP","SFD","LU0080751232.USD","RILY","BCRX","CTAS","SG9999014906.USD","NCLH","MACW.SI","BK4127","TWLO","AGIO","LU0097036916.USD","NFE","SG9999002224.SGD","MDT","AXSM","AMRX","LU0158827781.USD","ABR","IVVD","BMY","SEM","LU0354030511.USD","DPZ","NMIH"],"gpt_icon":1},{"id":"2513773319","title":"BUZZ-FDA 接受治療結直腸癌的組合藥物申請後，百時美施貴寶公司股價上漲","url":"https://stock-news.laohu8.com/highlight/detail?id=2513773319","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2513773319?lang=zh_tw&edition=fundamental","pubTime":"2025-02-24 23:43","pubTimestamp":1740411837,"startTime":"0","endTime":"0","summary":"2月24日 -  ** 制药商百时美施贵宝BMY.N股价上涨3.2%，报57.61美元 ** 该公司称， ，美国食品和药物管理局已接受其上市申请的审查，该申请旨在批准百时美施贵宝公司的Opdivo和Yervoy联合疗法，作为结直肠癌患者的一线治疗选择。** FDA将于6月23日前做出决定 ** Opdivo plus Yervoy已被批准用于治疗皮肤癌、肺癌、肾癌、结肠癌和食道癌。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250224:nL3S3PF169:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0321505439.SGD","LU1291159041.SGD","LU2360032135.SGD","BK4532","LU1670711040.USD","LU0114720955.EUR","LU1989771016.USD","LU0096364046.USD","IE00BJT1NW94.SGD","LU1093756325.SGD","LU1868837136.USD","LU1868836914.USD","LU1571399168.USD","LU1670711123.USD","LU2133065610.SGD","LU0321505868.SGD","LU1093756168.USD","BK4581","LU2242646821.SGD","BK4007","LU1868836757.USD","LU0225284248.USD","LU1670710588.SGD","LU1261432733.SGD","LU1868837300.USD","LU0882574055.USD","BK4534","LU2125154778.USD","LU0237698245.USD","BK4585","LU0225771236.USD","LU0306807586.USD","BMY","LU0061475181.USD","LU0306806265.USD","LU2242652126.USD","LU0456855351.SGD","IE0009355771.USD","LU2125154935.USD","LU1868836591.USD","LU1323610961.USD","LU1430594728.SGD","LU0985481810.HKD","LU0868494617.USD","IE0002141913.USD","LU1032466523.USD","LU1585245621.USD","LU1718418525.SGD","IE00B2B36J28.USD","BK4588"],"gpt_icon":0},{"id":"2513077817","title":"百時美施貴寶稱FDA已接受其結直腸癌藥物申請","url":"https://stock-news.laohu8.com/highlight/detail?id=2513077817","media":"环球市场播报","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2513077817?lang=zh_tw&edition=fundamental","pubTime":"2025-02-24 23:28","pubTimestamp":1740410880,"startTime":"0","endTime":"0","summary":"百时美施贵宝周一报告称，美国食品与药品管理局已接受其Opdivo加Yervoy作为结直肠癌的潜在一线治疗选择的补充生物制品许可申请。　　这种药物组合适用于患有不可切除或转移性结直肠癌的成人和12岁及以上儿童，这些结直肠癌具有高度微卫星不稳定性或错配修复缺陷。　　百时美施贵宝公司补充说，FDA已授予其申请突破性疗法认定和优先审评地位。它已将《处方药使用者费用法案》的截止日期定为6月23日。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/usstock/c/2025-02-24/doc-inemreny9705104.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["LU0306807586.USD","LU1032466523.USD","LU1074936037.SGD","LU1718418525.SGD","LU2125154935.USD","IE0002141913.USD","LU0114720955.EUR","IE00B2B36J28.USD","LU1989771016.USD","BMY","LU2125154778.USD","LU0237698245.USD","LU0321505439.SGD","LU2360032135.SGD","IE00BSNM7G36.USD","LU0321505868.SGD","LU0225771236.USD","LU2133065610.SGD","LU1670711040.USD","LU0061475181.USD","LU1868836757.USD","IE00BFTCPJ56.SGD","LU0882574055.USD","LU0306806265.USD","LU1670710588.SGD","BK4532","LU0225284248.USD","IE00BJT1NW94.SGD","IE0009355771.USD","BK4007","LU1430594728.SGD","BK4559","LU1670710661.SGD","LU0868494617.USD","BK4588","LU1868836914.USD","LU1291159041.SGD","BK4585","LU2242646821.SGD","BK4581","LU1571399168.USD","LU1585245621.USD","LU1093756168.USD","LU0456855351.SGD","IE00BJJMRZ35.SGD","LU1670711123.USD","LU1868837300.USD","LU1261432733.SGD","LU0985481810.HKD","LU1868836591.USD"],"gpt_icon":0},{"id":"1115640094","title":"摩根大通頂級生物醫藥股精選：點名三隻潛力股，禮來仍是首選","url":"https://stock-news.laohu8.com/highlight/detail?id=1115640094","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1115640094?lang=zh_tw&edition=fundamental","pubTime":"2025-02-21 14:45","pubTimestamp":1740120331,"startTime":"0","endTime":"0","summary":"摩根大通更新了一批生物制药股名单，这些股票在今年经历了一段冷热不均的时期后，可能会迎来上涨。摩根大通在这一领域的首选股票仍然是 $礼来$ 。展望未来，摩根大通看好礼来股票持续增长——今年迄今礼来股价已上涨13%，且过去一年约上涨16%。尽管在第四季度期间Zepbound和Mounjaro的需求激增，礼来公布的第四季度业绩却喜忧参半。摩根大通认为， $吉利德科学$ 同样是一个有吸引力的公司，因为其2025年产品管线及强劲的季度业绩。","market":"us","thumbnail":"https://community-static.tradeup.com/news/feea3873ee051fbf4de496a30ae642f4","type":0,"news_type":0,"thumbnails":["https://community-static.tradeup.com/news/feea3873ee051fbf4de496a30ae642f4"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":"摩根大通顶级生物医药股精选：点名三只潜力股，礼来仍是首选","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BMY","LLY","GILD"],"gpt_icon":1},{"id":"2512428944","title":"百時美施貴寶重磅免疫療法組合顯著延長肺癌患者生命","url":"https://stock-news.laohu8.com/highlight/detail?id=2512428944","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2512428944?lang=zh_tw&edition=fundamental","pubTime":"2025-02-20 20:59","pubTimestamp":1740056388,"startTime":"0","endTime":"0","summary":"结果显示，与仅接受新辅助化疗相比，Opdivo组合在总生存期这一关键性次要终点方面具有统计学显著且具有临床意义的改善。新闻稿表示，Opdivo是首个只在新辅助治疗阶段使用，就显著改善这一患者群体总生存期的免疫肿瘤学疗法。据悉，Opdivo是一种PD1免疫检查点蛋白抑制剂，旨在利用机体自身免疫系统帮助恢复抗肿瘤免疫反应。通过调动机体自身免疫系统对抗癌症，Opdivo已成为多种癌症的重要治疗选择。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250220210516988c58ef&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250220210516988c58ef&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0306807586.USD","LU1323610961.USD","LU1093756168.USD","IE00BSNM7G36.USD","LU1261432733.SGD","LU1032466523.USD","LU0096364046.USD","LU1670710661.SGD","LU1670711123.USD","LU1868837300.USD","LU0237698245.USD","LU1074936037.SGD","LU0114720955.EUR","BK4559","LU0061475181.USD","LU1868837136.USD","LU0985481810.HKD","LU0225771236.USD","LU1093756325.SGD","LU2242646821.SGD","IE00BFTCPJ56.SGD","BK4581","LU0882574055.USD","IE0002141913.USD","BK4585","LU1868836757.USD","LU0225284248.USD","LU1585245621.USD","LU0456855351.SGD","BK4588","IE00BJT1NW94.SGD","LU0868494617.USD","LU2242652126.USD","IE00BJJMRZ35.SGD","BMY","LU1571399168.USD","LU2125154935.USD","LU0321505868.SGD","IE0009355771.USD","LU2133065610.SGD","LU0321505439.SGD","LU0306806265.USD","LU1670710588.SGD","LU1670711040.USD","LU2360032135.SGD","LU1868836591.USD","LU1291159041.SGD","LU1989771016.USD","LU1868836914.USD","BK4534"],"gpt_icon":0},{"id":"2511292611","title":"百時美施貴寶下跌3.03%，報54.275美元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2511292611","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2511292611?lang=zh_tw&edition=fundamental","pubTime":"2025-02-15 03:52","pubTimestamp":1739562766,"startTime":"0","endTime":"0","summary":"2月15日，百时美施贵宝(BMY)盘中下跌3.03%，截至03:52，报54.275美元/股，成交3.74亿美元。财务数据显示，截至2024年12月31日，百时美施贵宝收入总额483.0亿美元，同比增长7.32%；归母净利润-89.48亿美元，同比减少211.5%。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/02/15035248179642.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["LU0306806265.USD","LU1670710661.SGD","LU2242652126.USD","BK4534","LU0985481810.HKD","LU1718418525.SGD","BK4581","LU0456855351.SGD","LU1093756168.USD","LU1571399168.USD","LU1323610961.USD","BK4585","LU1868836757.USD","LU1585245621.USD","LU1670710588.SGD","IE00BFTCPJ56.SGD","LU1868836591.USD","LU2360032135.SGD","LU1868837300.USD","IE00BSNM7G36.USD","LU2125154778.USD","LU1093756325.SGD","LU0237698245.USD","BK4532","BMY","IE00B2B36J28.USD","LU2242646821.SGD","IE0009355771.USD","IE00BJT1NW94.SGD","BK4007","LU0225771236.USD","LU0321505868.SGD","LU1430594728.SGD","LU1670711123.USD","BK4559","LU2125154935.USD","LU1291159041.SGD","IE0002141913.USD","LU0114720955.EUR","LU0061475181.USD","LU1032466523.USD","LU0868494617.USD","LU1261432733.SGD","BK4588","LU0882574055.USD","LU0321505439.SGD","LU1868836914.USD","LU1074936037.SGD","LU0306807586.USD","LU0096364046.USD"],"gpt_icon":0},{"id":"2511365712","title":"百時美施貴寶PD-1+LAG-3組合療法一項III期研究失敗","url":"https://stock-news.laohu8.com/highlight/detail?id=2511365712","media":"医药魔方Info","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2511365712?lang=zh_tw&edition=fundamental","pubTime":"2025-02-14 16:55","pubTimestamp":1739523355,"startTime":"0","endTime":"0","summary":"Opdualag是首个获得批准的PD-1+LAG-3组合抗体疗法，2022年3月，FDA批准该药用于治疗患有不可切除或转移性黑色素瘤的12岁及以上儿童和成人患者。临床前研究表明，抑制LAG-3可能促进抗肿瘤反应，同时抑制LAG-3和PD-1可能会增强某些癌症的抗肿瘤反应，从而使治疗效果优于PD-1单药治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250214172812abceb7cb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250214172812abceb7cb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4534","LU2242652126.USD","LU0114720955.EUR","IE00BSNM7G36.USD","LU1718418525.SGD","LU2133065610.SGD","LU0306806265.USD","LU2242646821.SGD","LU1585245621.USD","LU0306807586.USD","IE00BFTCPJ56.SGD","BK4581","LU0225284248.USD","BK4588","LU1169589451.USD","LU1670710661.SGD","LU1291159041.SGD","BK4585","LU1074936037.SGD","BK4559","LU1868837136.USD","LU1032466523.USD","LU0985481810.HKD","LU1868836914.USD","LU0096364046.USD","BK4532","LU0882574055.USD","LU0456855351.SGD","BK4023","LU1868836757.USD","BMY","LU1430594728.SGD","LU2125154778.USD","IE0002141913.USD","LU2125154935.USD","PD","LU1261432733.SGD","LU0225771236.USD","IE00B2B36J28.USD","LU0321505868.SGD","LU1670711040.USD","III","IE00BJT1NW94.SGD","IE00BJJMRZ35.SGD","LU1169590202.USD","LU1868837300.USD","LU1670711123.USD","LU0321505439.SGD","LU1093756325.SGD","LU0061475181.USD"],"gpt_icon":0},{"id":"2511362406","title":"施貴寶2024財年實現淨利潤-89.48億美元，同比減少211.50%","url":"https://stock-news.laohu8.com/highlight/detail?id=2511362406","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2511362406?lang=zh_tw&edition=fundamental","pubTime":"2025-02-14 14:00","pubTimestamp":1739512851,"startTime":"0","endTime":"0","summary":"2月14日，施贵宝公布财报，公告显示公司2024财年净利润为-89.48亿美元，同比减少211.50%；其中营业收入为483.00亿美元，同比增加7.32%，每股基本收益为-4.41美元。机构评级：截至2025年2月14日，当前有20家机构对施贵宝目标价做出预测，其中目标均价为60.65美元，其中最低目标价为37.00美元，最高目标价为70.00美元。百时美施贵宝的一个重点是免疫肿瘤学，该公司在药物开发方面处于领先地位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250214140053abce7b30&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250214140053abce7b30&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BMY"],"gpt_icon":0},{"id":"2510590153","title":"百時美施貴寶上漲1.22%，報56.205美元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2510590153","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2510590153?lang=zh_tw&edition=fundamental","pubTime":"2025-02-12 03:55","pubTimestamp":1739303734,"startTime":"0","endTime":"0","summary":"2月12日，百时美施贵宝(BMY)盘中上涨1.22%，截至03:55，报56.205美元/股，成交2.68亿美元。财务数据显示，截至2024年12月31日，百时美施贵宝收入总额483.0亿美元，同比增长7.32%；归母净利润-89.48亿美元，同比减少211.5%。大事提醒：2月7日，百时美施贵宝获富国银行上调目标价至62美元，最新评级Equal Weight。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/02/12035548092763.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["LU0096364046.USD","LU1868836914.USD","LU1093756168.USD","LU0868494617.USD","LU0225771236.USD","BK4585","LU1093756325.SGD","LU1261432733.SGD","LU1670711123.USD","LU1670710661.SGD","LU2133065610.SGD","LU0882574055.USD","LU1868836757.USD","BK4559","LU0321505868.SGD","LU2125154778.USD","LU0985481810.HKD","LU1291159041.SGD","LU1430594728.SGD","LU1571399168.USD","IE00BJT1NW94.SGD","LU1670710588.SGD","LU1670711040.USD","BK4007","BK4532","LU0306806265.USD","LU1718418525.SGD","LU2360032135.SGD","LU1989771016.USD","IE0002141913.USD","IE00BSNM7G36.USD","IE00B2B36J28.USD","LU1323610961.USD","LU1868837300.USD","LU2242646821.SGD","LU0456855351.SGD","IE00BFTCPJ56.SGD","LU1074936037.SGD","LU1868836591.USD","LU0237698245.USD","BMY","LU2242652126.USD","IE00BJJMRZ35.SGD","LU0321505439.SGD","LU1868837136.USD","BK4534","LU0306807586.USD","IE0009355771.USD","LU1032466523.USD","LU0225284248.USD"],"gpt_icon":0},{"id":"2510386642","title":"百時美施貴寶稱淋巴瘤藥物2期試驗數據積極","url":"https://stock-news.laohu8.com/highlight/detail?id=2510386642","media":"环球市场播报","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2510386642?lang=zh_tw&edition=fundamental","pubTime":"2025-02-10 23:11","pubTimestamp":1739200260,"startTime":"0","endTime":"0","summary":"百时美施贵宝（Bristol Myers Squibb）公司周一宣布，评估Breyanzi药物用于治疗复发难治性惰性B细胞非霍奇金淋巴瘤成人患者的 TRANSCEND FL二期试验在边缘区淋巴瘤队列研究中达到了主要终点。\n　　该2期试验显示了具有统计学和临床意义的总体缓解率（ORR）。它还达到了完全缓解率（CRR）的关键次要终点，未观察到新的安全性信号。\n　　百时美施贵宝公司指出：“凭借这些数据，Breyanzi证明了其针对第五种癌症类型的疗效和可控的安全性，这是所有针对CD19的CAR-T细胞疗法中数据最高的。”\n\n\n\n海量资讯、精准解读，尽在新浪财经APP\n\n责任编辑：张俊 SF065","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/usstock/c/2025-02-10/doc-ineizkuz3946254.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["LU0061475181.USD","IE00BJJMRZ35.SGD","LU1868836591.USD","BK4581","IE0002141913.USD","LU2125154935.USD","LU2242652126.USD","LU2242646821.SGD","LU1291159041.SGD","LU1093756325.SGD","IE00B2B36J28.USD","BK4007","BK4585","LU1670710588.SGD","LU1670711040.USD","BK4588","LU1585245621.USD","LU1868837300.USD","IE0009355771.USD","LU1571399168.USD","LU0237698245.USD","LU2133065610.SGD","LU0321505439.SGD","BK4534","BK4532","LU0882574055.USD","LU1989771016.USD","LU1868837136.USD","IE00BJT1NW94.SGD","LU0456855351.SGD","LU1868836757.USD","LU1032466523.USD","BMY","LU0321505868.SGD","LU2360032135.SGD","LU0985481810.HKD","LU1670711123.USD","LU1074936037.SGD","LU0306806265.USD","LU0225771236.USD","LU1670710661.SGD","LU1430594728.SGD","LU0306807586.USD","BK4559","LU0225284248.USD","LU1868836914.USD","LU0114720955.EUR","IE00BFTCPJ56.SGD","IE00BSNM7G36.USD","LU1093756168.USD"],"gpt_icon":0},{"id":"2509728724","title":"百時美施貴寶2024年營收同比增長7% 預計今年成熟產品收入至少下降18%","url":"https://stock-news.laohu8.com/highlight/detail?id=2509728724","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2509728724?lang=zh_tw&edition=fundamental","pubTime":"2025-02-07 23:38","pubTimestamp":1738942736,"startTime":"0","endTime":"0","summary":"2月6日，百时美施贵宝（BMS）公布2024年业绩，公司实现总营收483.00亿美元，同比增长7%；研发投入111.59亿美元，同比增长20%。但是，BMS给出的业绩指引却低于分析师预估。公司预计2025年的营收约为455亿美元，成熟产品可能将面临18%—20%的收入下降，其中来那度胺（Revlimid）的收入可能较2024年减少一半多。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202502073313753257.html","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202502073313753257.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BMY"],"gpt_icon":0}],"pageSize":20,"totalPage":7,"pageCount":3,"totalSize":130,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/BMY\",params:#limit:5,,,undefined,":[{"date":"2025-04-24","symbol":"BMY","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":"2025/03","expectedEps":1.54,"defaultRemindTime":1745481600000,"name":null,"time":"盤前","dateTimestamp":1745467200000,"actualEps":null},{"date":"2025-04-04","symbol":"BMY","amount":0.62,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-04-04","defaultRemindTime":1743773400000,"name":"施贵宝","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-05-01","payableDate":"2025-04-04","currency":"USD","dateTimestamp":1743739200000,"payDate":"2025-05-01"},{"market":"US","date":"2025-02-06","symbol":"BMY","fiscalQuarterEnding":"2024/12","expectedEps":1.46,"name":null,"time":"盤前","type":"earning","dateTimestamp":1738818000000,"reportTimeType":"pre","actualEps":1.67},{"date":"2025-01-03","symbol":"BMY","amount":0.62,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-01-03","defaultRemindTime":1735914600000,"name":"施贵宝","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-02-03","payableDate":"2025-01-03","currency":"USD","dateTimestamp":1735880400000,"payDate":"2025-02-03"},{"market":"US","date":"2024-10-31","symbol":"BMY","fiscalQuarterEnding":"2024/09","expectedEps":1.49,"name":null,"time":"盤前","type":"earning","dateTimestamp":1730347200000,"reportTimeType":"pre","actualEps":1.8}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"BMY\",market:\"US\",,,undefined,":[{"executeDate":"2015-07-01","recordDate":"2015-07-06","paymentDate":"2015-08-03","value":0.37,"currency":"USD"},{"executeDate":"2015-09-30","recordDate":"2015-10-02","paymentDate":"2015-11-02","value":0.37,"currency":"USD"},{"executeDate":"2015-12-30","recordDate":"2016-01-04","paymentDate":"2016-02-01","value":0.38,"currency":"USD"},{"executeDate":"2016-03-30","recordDate":"2016-04-01","paymentDate":"2016-05-02","value":0.38,"currency":"USD"},{"executeDate":"2016-06-29","recordDate":"2016-07-01","paymentDate":"2016-08-01","value":0.38,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"BMY\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.1429,"buy":0.1071,"hold":0.6786,"sell":0.0714,"strongSell":0,"meanLabel":"HOLD","meanPercent":0.6786,"analysts":28,"updateTime":1745294400000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/BMY\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"BMY","date":"2025-04-22","current":-11.12889,"percent":0.493095,"low":-3427.632189,"twenty":-24.204041,"median":12.10488,"eighty":23.409797,"high":152.008162,"avg":-163.317688,"sd":702.176262,"marketCap":99581310812},"quantilePoints":[{"date":"2020-04-24","current":40.953284,"twenty":26.163897,"median":40.595255,"eighty":57.731222,"marketCap":140838343724},{"date":"2020-05-01","current":39.644095,"twenty":26.163897,"median":40.646079,"eighty":57.731222,"marketCap":136336041651},{"date":"2020-05-08","current":144.797914,"twenty":26.163897,"median":40.716632,"eighty":57.780539,"marketCap":138137209542},{"date":"2020-05-15","current":152.008162,"twenty":26.163897,"median":40.828913,"eighty":58.028862,"marketCap":145015786397},{"date":"2020-05-22","current":144.181248,"twenty":26.163897,"median":40.989755,"eighty":58.258767,"marketCap":137548910206},{"date":"2020-05-29","current":141.64343,"twenty":26.163897,"median":41.152517,"eighty":58.434572,"marketCap":135127832168},{"date":"2020-06-05","current":145.462015,"twenty":26.163897,"median":41.507602,"eighty":58.543425,"marketCap":138770762674},{"date":"2020-06-12","current":133.223568,"twenty":26.163897,"median":41.630405,"eighty":58.70227,"marketCap":127095283538},{"date":"2020-06-19","current":133.792798,"twenty":26.163897,"median":41.779831,"eighty":59.065322,"marketCap":127638329079},{"date":"2020-06-26","current":136.472923,"twenty":26.163897,"median":41.955835,"eighty":59.303982,"marketCap":130195168502},{"date":"2020-07-02","current":140.26779,"twenty":26.163897,"median":42.192232,"eighty":59.612319,"marketCap":133815472110},{"date":"2020-07-10","current":136.212026,"twenty":26.163897,"median":42.354947,"eighty":59.954728,"marketCap":129946272629},{"date":"2020-07-17","current":143.232531,"twenty":26.163897,"median":42.505381,"eighty":60.343483,"marketCap":136643834304},{"date":"2020-07-24","current":137.208179,"twenty":26.163897,"median":42.754058,"eighty":60.719618,"marketCap":130896602326},{"date":"2020-07-31","current":139.12933,"twenty":26.163897,"median":43.2132,"eighty":60.965815,"marketCap":132729381028},{"date":"2020-08-07","current":-244.289683,"twenty":26.104809,"median":43.30835,"eighty":63.241479,"marketCap":137535091427},{"date":"2020-08-14","current":-252.857036,"twenty":25.671207,"median":43.30835,"eighty":63.241479,"marketCap":142358511546},{"date":"2020-08-21","current":-248.973703,"twenty":24.738199,"median":43.30835,"eighty":63.241479,"marketCap":140172194950},{"date":"2020-08-28","current":-249.694322,"twenty":24.53695,"median":43.30835,"eighty":63.241479,"marketCap":140577903184},{"date":"2020-09-04","current":-240.006006,"twenty":24.217273,"median":43.30835,"eighty":63.241479,"marketCap":135123381368},{"date":"2020-09-11","current":-236.162707,"twenty":23.958745,"median":43.30835,"eighty":63.241479,"marketCap":132959604118},{"date":"2020-09-18","current":-237.283669,"twenty":23.923139,"median":43.30835,"eighty":63.241479,"marketCap":133590705816},{"date":"2020-09-25","current":-238.164425,"twenty":23.703169,"median":43.30835,"eighty":63.241479,"marketCap":134086571436},{"date":"2020-10-02","current":-235.081779,"twenty":23.363915,"median":43.30835,"eighty":63.241479,"marketCap":132351041767},{"date":"2020-10-09","current":-247.492432,"twenty":17.593463,"median":43.30835,"eighty":63.241479,"marketCap":139338239135},{"date":"2020-10-16","current":-245.170439,"twenty":17.05085,"median":43.30835,"eighty":63.241479,"marketCap":138030957047},{"date":"2020-10-23","current":-240.726625,"twenty":16.915253,"median":43.30835,"eighty":63.241479,"marketCap":135529089602},{"date":"2020-10-30","current":-234.000852,"twenty":16.878905,"median":43.30835,"eighty":63.241479,"marketCap":131742479415},{"date":"2020-11-06","current":-3276.639701,"twenty":16.797113,"median":43.30835,"eighty":63.241479,"marketCap":144172146848},{"date":"2020-11-13","current":-3267.395263,"twenty":16.644024,"median":43.30835,"eighty":63.241479,"marketCap":143765391575},{"date":"2020-11-20","current":-3164.165705,"twenty":16.603263,"median":43.30835,"eighty":63.241479,"marketCap":139223291023},{"date":"2020-11-27","current":-3238.121209,"twenty":16.551974,"median":43.30835,"eighty":63.241479,"marketCap":142477333209},{"date":"2020-12-04","current":-3200.116297,"twenty":16.449584,"median":43.30835,"eighty":63.241479,"marketCap":140805117086},{"date":"2020-12-11","current":-3118.457095,"twenty":16.271128,"median":43.30835,"eighty":63.241479,"marketCap":137212112172},{"date":"2020-12-18","current":-3241.716269,"twenty":16.177691,"median":43.24944,"eighty":63.241479,"marketCap":142635515816},{"date":"2020-12-24","current":-3140.54103,"twenty":15.969441,"median":43.24944,"eighty":63.241479,"marketCap":138183805325},{"date":"2020-12-31","current":-3185.73606,"twenty":15.745139,"median":43.24944,"eighty":63.241479,"marketCap":140172386661},{"date":"2021-01-08","current":-3209.360735,"twenty":15.520794,"median":43.24944,"eighty":63.241479,"marketCap":141211872359},{"date":"2021-01-15","current":-3417.360591,"twenty":15.454453,"median":43.24944,"eighty":63.241479,"marketCap":150363866007},{"date":"2021-01-22","current":-3315.671773,"twenty":15.292279,"median":43.24944,"eighty":63.241479,"marketCap":145889558002},{"date":"2021-01-29","current":-3154.921267,"twenty":15.193414,"median":43.24944,"eighty":63.241479,"marketCap":138816535750},{"date":"2021-02-05","current":-15.270556,"twenty":15.111639,"median":43.24944,"eighty":63.241479,"marketCap":137664062476},{"date":"2021-02-12","current":-14.909163,"twenty":15.037512,"median":43.24944,"eighty":63.241479,"marketCap":134406104428},{"date":"2021-02-19","current":-15.060765,"twenty":14.994264,"median":43.24944,"eighty":63.241479,"marketCap":135772794271},{"date":"2021-02-26","current":-15.24219,"twenty":14.895142,"median":43.24944,"eighty":63.241479,"marketCap":137408341133},{"date":"2021-03-05","current":-15.018515,"twenty":14.827729,"median":43.252713,"eighty":64.853776,"marketCap":135391913495},{"date":"2021-03-12","current":-15.070706,"twenty":14.750073,"median":43.252713,"eighty":64.853776,"marketCap":135862413277},{"date":"2021-03-19","current":-15.582672,"twenty":14.671279,"median":43.252713,"eighty":64.853776,"marketCap":140477792093},{"date":"2021-03-26","current":-15.84441,"twenty":14.611498,"median":43.24944,"eighty":63.241479,"marketCap":142837352227},{"date":"2021-04-01","current":-15.59413,"twenty":14.591649,"median":43.24944,"eighty":63.241479,"marketCap":140581085012},{"date":"2021-04-09","current":-15.514834,"twenty":14.520487,"median":43.252713,"eighty":64.853776,"marketCap":139866228072},{"date":"2021-04-16","current":-16.221067,"twenty":14.424522,"median":43.252713,"eighty":64.853776,"marketCap":146232922690},{"date":"2021-04-23","current":-16.357358,"twenty":14.234366,"median":43.246167,"eighty":64.853776,"marketCap":147461583055},{"date":"2021-04-30","current":-22.411016,"twenty":14.031315,"median":41.99272,"eighty":64.853776,"marketCap":139374107187},{"date":"2021-05-07","current":-23.136268,"twenty":13.765653,"median":40.725784,"eighty":64.853776,"marketCap":143884451572},{"date":"2021-05-14","current":-23.294244,"twenty":13.598846,"median":40.216454,"eighty":64.853776,"marketCap":144866902824},{"date":"2021-05-21","current":-24.073352,"twenty":13.387812,"median":39.861196,"eighty":64.853776,"marketCap":149712173772},{"date":"2021-05-28","current":-23.595834,"twenty":13.305536,"median":39.584885,"eighty":64.853776,"marketCap":146742491578},{"date":"2021-06-04","current":-23.315786,"twenty":13.183703,"median":39.110931,"eighty":64.853776,"marketCap":145000873449},{"date":"2021-06-11","current":-24.177472,"twenty":13.076111,"median":38.321748,"eighty":64.853776,"marketCap":150359698461},{"date":"2021-06-18","current":-23.865111,"twenty":12.918943,"median":37.341182,"eighty":64.853776,"marketCap":148417124394},{"date":"2021-06-25","current":-23.962051,"twenty":12.713253,"median":37.032625,"eighty":64.853776,"marketCap":149019992208},{"date":"2021-07-02","current":-24.037448,"twenty":12.656819,"median":36.735495,"eighty":64.853776,"marketCap":149488889397},{"date":"2021-07-09","current":-24.112846,"twenty":12.542371,"median":36.569788,"eighty":64.853776,"marketCap":149957786585},{"date":"2021-07-16","current":-24.163111,"twenty":12.276028,"median":36.398367,"eighty":64.853776,"marketCap":150270384711},{"date":"2021-07-23","current":-24.536508,"twenty":12.058207,"median":36.20409,"eighty":64.853776,"marketCap":152592542216},{"date":"2021-07-30","current":-29.693807,"twenty":11.96591,"median":36.009813,"eighty":61.057,"marketCap":150814846842},{"date":"2021-08-06","current":-29.803185,"twenty":-14.753585,"median":35.906961,"eighty":60.876911,"marketCap":151370375230},{"date":"2021-08-13","current":-29.536304,"twenty":-14.987324,"median":35.781252,"eighty":60.876911,"marketCap":150014885963},{"date":"2021-08-20","current":-30.275696,"twenty":-15.059273,"median":34.627419,"eighty":60.876911,"marketCap":153770257867},{"date":"2021-08-27","current":-29.138169,"twenty":-15.115938,"median":34.17561,"eighty":60.876911,"marketCap":147992762629},{"date":"2021-09-03","current":-28.705034,"twenty":-15.248154,"median":33.35279,"eighty":60.876911,"marketCap":145792870212},{"date":"2021-09-10","current":-27.62001,"twenty":-15.348311,"median":32.979745,"eighty":60.876911,"marketCap":140282028600},{"date":"2021-09-17","current":-26.823741,"twenty":-15.441509,"median":32.518541,"eighty":60.876911,"marketCap":136237781934},{"date":"2021-09-24","current":-26.35123,"twenty":-15.542928,"median":32.364263,"eighty":60.876911,"marketCap":133837899297},{"date":"2021-10-01","current":-26.036223,"twenty":-15.613954,"median":32.061419,"eighty":60.876911,"marketCap":132237977539},{"date":"2021-10-08","current":-25.051826,"twenty":-15.777999,"median":31.581441,"eighty":60.876911,"marketCap":127238222044},{"date":"2021-10-15","current":-25.533087,"twenty":-16.234944,"median":30.750116,"eighty":60.876911,"marketCap":129682546953},{"date":"2021-10-22","current":-25.200579,"twenty":-16.36727,"median":30.429194,"eighty":60.876911,"marketCap":127993740652},{"date":"2021-10-29","current":-23.982843,"twenty":-22.664495,"median":30.34167,"eighty":60.876911,"marketCap":129627264204},{"date":"2021-11-05","current":-24.414041,"twenty":-23.13914,"median":30.156897,"eighty":60.876911,"marketCap":131957891385},{"date":"2021-11-12","current":-24.405828,"twenty":-23.227463,"median":30.035336,"eighty":60.876911,"marketCap":131913498487},{"date":"2021-11-19","current":-23.748763,"twenty":-23.330148,"median":29.933224,"eighty":60.876911,"marketCap":128362066591},{"date":"2021-11-26","current":-23.214899,"twenty":-23.393674,"median":29.797076,"eighty":60.876911,"marketCap":125476528175},{"date":"2021-12-03","current":-23.128659,"twenty":-23.393674,"median":29.729002,"eighty":60.876911,"marketCap":125010402739},{"date":"2021-12-10","current":-23.145086,"twenty":-23.461298,"median":29.636615,"eighty":60.876911,"marketCap":125099188536},{"date":"2021-12-17","current":-25.280544,"twenty":-23.568548,"median":27.951968,"eighty":60.876911,"marketCap":136641342198},{"date":"2021-12-23","current":-25.48177,"twenty":-23.634806,"median":27.65765,"eighty":60.876911,"marketCap":137728968216},{"date":"2021-12-31","current":-25.60497,"twenty":-23.766579,"median":27.039995,"eighty":60.876911,"marketCap":138394861697},{"date":"2022-01-07","current":-25.802089,"twenty":-23.903887,"median":26.592299,"eighty":60.865513,"marketCap":139460291266},{"date":"2022-01-14","current":-26.664486,"twenty":-23.969949,"median":26.503175,"eighty":60.865513,"marketCap":144121545629},{"date":"2022-01-21","current":-26.093661,"twenty":-24.000827,"median":26.434777,"eighty":60.865513,"marketCap":141036239169},{"date":"2022-01-28","current":-26.656272,"twenty":-24.081403,"median":26.28969,"eighty":60.865513,"marketCap":144077152730},{"date":"2022-02-04","current":20.625497,"twenty":-24.122181,"median":26.107856,"eighty":60.865513,"marketCap":144254724325},{"date":"2022-02-11","current":20.843465,"twenty":-24.122181,"median":25.804687,"eighty":60.865513,"marketCap":145779193401},{"date":"2022-02-18","current":21.052274,"twenty":-24.122181,"median":24.80247,"eighty":60.865513,"marketCap":147239600991},{"date":"2022-02-25","current":21.441842,"twenty":-24.122181,"median":24.575651,"eighty":60.865513,"marketCap":149964242016},{"date":"2022-03-04","current":21.616368,"twenty":-24.122181,"median":24.306674,"eighty":60.865513,"marketCap":151184881195},{"date":"2022-03-11","current":21.463658,"twenty":-24.122181,"median":23.979644,"eighty":60.865513,"marketCap":150116821913},{"date":"2022-03-18","current":22.133715,"twenty":-24.122181,"median":23.933202,"eighty":60.865513,"marketCap":154803204476},{"date":"2022-03-25","current":22.26692,"twenty":-24.122181,"median":23.737758,"eighty":60.865513,"marketCap":155734841105},{"date":"2022-04-01","current":22.431005,"twenty":-24.122181,"median":23.392104,"eighty":60.865513,"marketCap":156882450469},{"date":"2022-04-08","current":23.631255,"twenty":-24.122181,"median":23.0415,"eighty":60.865513,"marketCap":165277000447},{"date":"2022-04-14","current":23.552252,"twenty":-24.122181,"median":23.0415,"eighty":60.865513,"marketCap":164724447790},{"date":"2022-04-22","current":23.017457,"twenty":-24.122181,"median":22.955165,"eighty":60.865513,"marketCap":160984091344},{"date":"2022-04-29","current":25.636645,"twenty":-24.122181,"median":22.930856,"eighty":60.865513,"marketCap":160254667678},{"date":"2022-05-06","current":26.113479,"twenty":-24.122181,"median":22.930856,"eighty":60.865513,"marketCap":163235357657},{"date":"2022-05-13","current":25.817161,"twenty":-24.122181,"median":22.930856,"eighty":60.865513,"marketCap":161383071741},{"date":"2022-05-20","current":25.949993,"twenty":-24.122181,"median":22.930856,"eighty":60.865513,"marketCap":162213406807},{"date":"2022-05-27","current":25.932963,"twenty":-24.122181,"median":22.930856,"eighty":60.865513,"marketCap":162106953593},{"date":"2022-06-03","current":25.602585,"twenty":-24.122181,"median":22.930856,"eighty":60.865513,"marketCap":160041761251},{"date":"2022-06-10","current":25.575338,"twenty":-24.122181,"median":22.930856,"eighty":60.865513,"marketCap":159871436109},{"date":"2022-06-17","current":25.125751,"twenty":-24.122181,"median":22.930856,"eighty":60.865513,"marketCap":157061071271},{"date":"2022-06-24","current":26.893443,"twenty":-24.131516,"median":22.892874,"eighty":60.876911,"marketCap":168110914838},{"date":"2022-07-01","current":26.17138,"twenty":-24.131516,"median":22.892874,"eighty":60.876911,"marketCap":163597298583},{"date":"2022-07-08","current":25.674111,"twenty":-24.131516,"median":22.892874,"eighty":60.876911,"marketCap":160488864747},{"date":"2022-07-15","current":25.766071,"twenty":-24.131516,"median":22.892874,"eighty":60.876911,"marketCap":161063712101},{"date":"2022-07-22","current":24.846463,"twenty":-24.131516,"median":22.892874,"eighty":60.876911,"marketCap":155315238569},{"date":"2022-07-29","current":23.80824,"twenty":-24.131516,"median":22.892874,"eighty":60.876911,"marketCap":157539125557},{"date":"2022-08-05","current":23.272571,"twenty":-24.131516,"median":22.892874,"eighty":60.876911,"marketCap":153994601994},{"date":"2022-08-12","current":24.385859,"twenty":-24.131516,"median":22.892874,"eighty":60.876911,"marketCap":161361232290},{"date":"2022-08-19","current":24.308413,"twenty":-24.131516,"median":22.892874,"eighty":60.876911,"marketCap":160848771052},{"date":"2022-08-26","current":22.972467,"twenty":-24.131516,"median":22.892874,"eighty":60.876911,"marketCap":152008814698},{"date":"2022-09-02","current":22.139921,"twenty":-24.131516,"median":22.294813,"eighty":60.876911,"marketCap":146499856390},{"date":"2022-09-09","current":22.640094,"twenty":-24.131516,"median":22.251727,"eighty":60.876911,"marketCap":149809501885},{"date":"2022-09-16","current":23.078956,"twenty":-24.131516,"median":22.251727,"eighty":60.876911,"marketCap":152713448900},{"date":"2022-09-23","current":22.817575,"twenty":-24.131516,"median":22.251727,"eighty":60.876911,"marketCap":150983892222},{"date":"2022-09-30","current":22.940198,"twenty":-24.131516,"median":22.251727,"eighty":60.876911,"marketCap":151795289182},{"date":"2022-10-07","current":22.491656,"twenty":-24.131516,"median":22.251727,"eighty":60.876911,"marketCap":148827284512},{"date":"2022-10-14","current":22.788532,"twenty":-24.131516,"median":22.245911,"eighty":60.876911,"marketCap":150791719257},{"date":"2022-10-21","current":23.301613,"twenty":-24.131516,"median":22.245911,"eighty":60.876911,"marketCap":154186774959},{"date":"2022-10-28","current":25.54071,"twenty":-24.131516,"median":22.245911,"eighty":60.876911,"marketCap":170535320356},{"date":"2022-11-04","current":26.188951,"twenty":-24.131516,"median":22.245911,"eighty":60.876911,"marketCap":174863627979},{"date":"2022-11-11","current":25.251495,"twenty":-24.131516,"median":22.245911,"eighty":60.876911,"marketCap":168604229262},{"date":"2022-11-18","current":25.746817,"twenty":-24.131516,"median":22.245911,"eighty":60.876911,"marketCap":171911500215},{"date":"2022-11-25","current":26.34187,"twenty":-24.131516,"median":22.245911,"eighty":60.876911,"marketCap":175884664649},{"date":"2022-12-02","current":26.970165,"twenty":-24.131516,"median":22.245911,"eighty":60.876911,"marketCap":180079793576},{"date":"2022-12-09","current":26.205573,"twenty":-24.131516,"median":22.245911,"eighty":60.876911,"marketCap":174974610226},{"date":"2022-12-16","current":24.430389,"twenty":-24.131516,"median":22.245911,"eighty":60.876911,"marketCap":163121706273},{"date":"2022-12-23","current":24.23093,"twenty":-24.131516,"median":22.245911,"eighty":60.876911,"marketCap":161789919312},{"date":"2022-12-30","current":23.918444,"twenty":-24.131516,"median":22.245911,"eighty":60.876911,"marketCap":159703453073},{"date":"2023-01-06","current":24.267497,"twenty":-24.131516,"median":22.245911,"eighty":60.876911,"marketCap":162034080255},{"date":"2023-01-13","current":24.104606,"twenty":-24.131516,"median":22.245911,"eighty":60.876911,"marketCap":160946454236},{"date":"2023-01-20","current":24.649794,"twenty":-24.131516,"median":22.245911,"eighty":60.876911,"marketCap":164586671930},{"date":"2023-01-27","current":24.08466,"twenty":-24.131516,"median":22.245911,"eighty":60.876911,"marketCap":160813275540},{"date":"2023-02-03","current":26.118629,"twenty":-24.131516,"median":22.245911,"eighty":60.876911,"marketCap":165252565410},{"date":"2023-02-10","current":25.329282,"twenty":-24.131516,"median":22.245911,"eighty":60.555486,"marketCap":160258364307},{"date":"2023-02-17","current":23.588424,"twenty":-24.131516,"median":22.245911,"eighty":60.138319,"marketCap":149243959795},{"date":"2023-02-24","current":23.279927,"twenty":-24.131516,"median":22.245911,"eighty":59.828291,"marketCap":147292098136},{"date":"2023-03-03","current":22.988016,"twenty":-24.131516,"median":22.245911,"eighty":59.303982,"marketCap":145445175275},{"date":"2023-03-10","current":21.79715,"twenty":-24.131516,"median":22.190955,"eighty":58.624659,"marketCap":137910569514},{"date":"2023-03-17","current":22.069158,"twenty":-24.131516,"median":22.143065,"eighty":57.674063,"marketCap":139631565816},{"date":"2023-03-24","current":22.499062,"twenty":-24.131516,"median":22.143065,"eighty":57.089646,"marketCap":142351566870},{"date":"2023-03-31","current":23.040928,"twenty":-24.122181,"median":22.147947,"eighty":56.818785,"marketCap":145779951237},{"date":"2023-04-06","current":23.210469,"twenty":-24.122181,"median":22.147947,"eighty":56.570827,"marketCap":146852635917},{"date":"2023-04-14","current":23.499685,"twenty":-24.131516,"median":22.143065,"eighty":54.708084,"marketCap":148682509782},{"date":"2023-04-21","current":23.114063,"twenty":-24.131516,"median":22.143065,"eighty":52.238402,"marketCap":146242677962},{"date":"2023-04-28","current":19.428023,"twenty":-24.131516,"median":22.133715,"eighty":43.587843,"marketCap":142038275000},{"date":"2023-05-05","current":19.201013,"twenty":-24.131516,"median":22.049255,"eighty":42.979111,"marketCap":140378605761},{"date":"2023-05-12","current":19.850434,"twenty":-24.131516,"median":21.75269,"eighty":40.909864,"marketCap":145126520293},{"date":"2023-05-19","current":18.879176,"twenty":-24.131516,"median":21.57897,"eighty":40.438819,"marketCap":138025656966},{"date":"2023-05-26","current":18.551592,"twenty":-24.131516,"median":21.441842,"eighty":40.037509,"marketCap":135630691229},{"date":"2023-06-02","current":18.586075,"twenty":-24.131516,"median":21.323413,"eighty":39.672401,"marketCap":135882792885},{"date":"2023-06-09","current":18.767108,"twenty":-24.131516,"median":21.067856,"eighty":39.30989,"marketCap":137206326582},{"date":"2023-06-16","current":18.583201,"twenty":-24.131516,"median":20.924495,"eighty":38.76535,"marketCap":135861784414},{"date":"2023-06-23","current":18.764234,"twenty":-24.14085,"median":20.774901,"eighty":37.956903,"marketCap":137185318111},{"date":"2023-06-30","current":18.390674,"twenty":-24.150185,"median":19.657906,"eighty":36.490198,"marketCap":134454216832},{"date":"2023-07-07","current":18.229755,"twenty":-24.150185,"median":19.568826,"eighty":35.727263,"marketCap":133277742434},{"date":"2023-07-14","current":17.896425,"twenty":-24.150185,"median":19.258484,"eighty":33.43663,"marketCap":130840759754},{"date":"2023-07-21","current":18.324582,"twenty":-24.15952,"median":19.11768,"eighty":31.771888,"marketCap":133971021990},{"date":"2023-07-28","current":15.932591,"twenty":-24.15952,"median":18.915095,"eighty":27.682522,"marketCap":126871220392},{"date":"2023-08-04","current":16.063766,"twenty":-24.15952,"median":18.814521,"eighty":27.240851,"marketCap":127915771852},{"date":"2023-08-11","current":16.079507,"twenty":-24.15952,"median":18.65504,"eighty":26.887057,"marketCap":128041118028},{"date":"2023-08-18","current":16.30513,"twenty":-24.15952,"median":18.600443,"eighty":26.661838,"marketCap":129837746540},{"date":"2023-08-25","current":16.076884,"twenty":-24.15952,"median":18.534351,"eighty":26.588154,"marketCap":128020226998},{"date":"2023-09-01","current":16.173954,"twenty":-24.15952,"median":18.403605,"eighty":26.567923,"marketCap":128793195079},{"date":"2023-09-08","current":15.733204,"twenty":-24.15952,"median":18.315962,"eighty":26.505248,"marketCap":125283502172},{"date":"2023-09-15","current":15.607275,"twenty":-24.15952,"median":17.92516,"eighty":26.451358,"marketCap":124280732770},{"date":"2023-09-22","current":15.499711,"twenty":-24.15952,"median":17.785793,"eighty":26.356016,"marketCap":123424200572},{"date":"2023-09-29","current":15.253101,"twenty":-24.15952,"median":17.14351,"eighty":26.308627,"marketCap":121460443826},{"date":"2023-10-06","current":14.801857,"twenty":-24.15952,"median":16.994886,"eighty":26.256528,"marketCap":117867186802},{"date":"2023-10-13","current":14.759881,"twenty":-24.15952,"median":16.912197,"eighty":26.215546,"marketCap":117532930335},{"date":"2023-10-20","current":14.817598,"twenty":-24.15952,"median":16.861517,"eighty":26.181912,"marketCap":117992532978},{"date":"2023-10-27","current":13.009187,"twenty":-24.15952,"median":16.75383,"eighty":26.13539,"marketCap":107781117593},{"date":"2023-11-03","current":12.557292,"twenty":-24.15952,"median":16.645066,"eighty":26.102322,"marketCap":104037163348},{"date":"2023-11-10","current":12.380463,"twenty":-24.15952,"median":16.606678,"eighty":26.050188,"marketCap":102572137774},{"date":"2023-11-17","current":12.486069,"twenty":-24.15952,"median":16.545514,"eighty":25.981328,"marketCap":103447083603},{"date":"2023-11-24","current":12.220826,"twenty":-24.15952,"median":16.468598,"eighty":25.948631,"marketCap":101249545241},{"date":"2023-12-01","current":12.1275,"twenty":-24.15952,"median":16.323182,"eighty":25.871656,"marketCap":100476337299},{"date":"2023-12-08","current":12.319064,"twenty":-24.15952,"median":16.284141,"eighty":25.822267,"marketCap":102063448338},{"date":"2023-12-15","current":12.640794,"twenty":-24.15952,"median":16.244457,"eighty":25.741743,"marketCap":104728980980},{"date":"2023-12-22","current":12.589219,"twenty":-24.15952,"median":16.206012,"eighty":25.671391,"marketCap":104301681854},{"date":"2023-12-29","current":12.579395,"twenty":-24.15952,"median":16.17133,"eighty":25.63392,"marketCap":104220291545},{"date":"2024-01-05","current":12.780784,"twenty":-24.15952,"median":16.126731,"eighty":25.574657,"marketCap":105888792893},{"date":"2024-01-12","current":12.3338,"twenty":-24.15952,"median":16.052442,"eighty":25.53878,"marketCap":102185533803},{"date":"2024-01-19","current":12.301873,"twenty":-24.15952,"median":15.981387,"eighty":25.384604,"marketCap":101921015296},{"date":"2024-01-26","current":12.183987,"twenty":-24.15952,"median":15.915318,"eighty":25.326357,"marketCap":100944331580},{"date":"2024-02-02","current":11.953127,"twenty":-24.15952,"median":15.848219,"eighty":25.326357,"marketCap":99031659303},{"date":"2024-02-09","current":12.350536,"twenty":-24.15952,"median":15.711339,"eighty":25.326357,"marketCap":99113049612},{"date":"2024-02-16","current":12.458223,"twenty":-24.15952,"median":15.581954,"eighty":25.326357,"marketCap":99977242239},{"date":"2024-02-23","current":12.934478,"twenty":-24.15952,"median":15.510205,"eighty":25.326357,"marketCap":103799187786},{"date":"2024-03-01","current":12.788326,"twenty":-24.15952,"median":15.476991,"eighty":25.323432,"marketCap":102626315608},{"date":"2024-03-08","current":13.425852,"twenty":-24.15952,"median":15.421006,"eighty":25.323432,"marketCap":107742464938},{"date":"2024-03-15","current":13.226783,"twenty":-24.15952,"median":15.29517,"eighty":25.323432,"marketCap":106144932143},{"date":"2024-03-22","current":12.999995,"twenty":-24.15952,"median":15.228111,"eighty":25.323432,"marketCap":104324958073},{"date":"2024-03-28","current":13.418293,"twenty":-24.15952,"median":15.187513,"eighty":25.323432,"marketCap":107681799135},{"date":"2024-04-05","current":12.981358,"twenty":-24.15952,"median":15.120443,"eighty":25.326357,"marketCap":104175397951},{"date":"2024-04-12","current":12.405531,"twenty":-24.15952,"median":15.050664,"eighty":25.326357,"marketCap":99554388080},{"date":"2024-04-19","current":12.198436,"twenty":-24.15952,"median":15.01354,"eighty":25.326357,"marketCap":97892445934},{"date":"2024-04-26","current":-14.73835,"twenty":-24.15952,"median":14.996944,"eighty":25.323432,"marketCap":90611374291},{"date":"2024-05-03","current":-14.408633,"twenty":-24.15952,"median":14.996944,"eighty":25.323432,"marketCap":88584274195},{"date":"2024-05-10","current":-14.751538,"twenty":-24.15952,"median":14.897686,"eighty":25.323432,"marketCap":90692458295},{"date":"2024-05-17","current":-14.543817,"twenty":-24.15952,"median":14.883186,"eighty":25.323432,"marketCap":89415385234},{"date":"2024-05-24","current":-13.696444,"twenty":-24.15952,"median":14.851704,"eighty":25.323432,"marketCap":84205737987},{"date":"2024-05-31","current":-13.271109,"twenty":-24.15952,"median":14.843629,"eighty":25.323432,"marketCap":81590778864},{"date":"2024-06-07","current":-13.478831,"twenty":-24.15952,"median":14.843629,"eighty":25.323432,"marketCap":82867851924},{"date":"2024-06-14","current":-13.676661,"twenty":-24.15952,"median":14.80891,"eighty":25.326357,"marketCap":84084111982},{"date":"2024-06-21","current":-13.531586,"twenty":-24.15952,"median":14.706868,"eighty":25.329282,"marketCap":83192187939},{"date":"2024-06-28","current":-13.686553,"twenty":-24.161675,"median":14.733375,"eighty":25.346437,"marketCap":84144924984},{"date":"2024-07-05","current":-13.208463,"twenty":-24.161675,"median":14.649759,"eighty":25.346437,"marketCap":81205629845},{"date":"2024-07-12","current":-13.435968,"twenty":-24.161675,"median":14.578971,"eighty":25.346437,"marketCap":82604328912},{"date":"2024-07-15","current":-13.34035,"twenty":-24.161675,"median":14.578971,"eighty":25.346437,"marketCap":82016469884},{"date":"2024-08-02","current":-14.930382,"twenty":-24.197578,"median":14.814975,"eighty":25.39607,"marketCap":97659625724},{"date":"2024-08-09","current":-14.521245,"twenty":-24.197578,"median":14.814975,"eighty":25.39607,"marketCap":94983464089},{"date":"2024-08-16","current":-15.221736,"twenty":-24.197578,"median":14.814975,"eighty":25.39607,"marketCap":99565377191},{"date":"2024-08-23","current":-14.759908,"twenty":-24.197578,"median":14.814975,"eighty":25.39607,"marketCap":96544558376},{"date":"2024-08-30","current":-15.410807,"twenty":-24.197578,"median":14.814975,"eighty":25.39607,"marketCap":100802088250},{"date":"2024-09-06","current":-15.435603,"twenty":-24.197578,"median":14.814975,"eighty":25.39607,"marketCap":100964279864},{"date":"2024-09-13","current":-14.952078,"twenty":-24.197578,"median":14.814975,"eighty":25.39607,"marketCap":97801543386},{"date":"2024-09-20","current":-15.193841,"twenty":-24.197578,"median":14.814975,"eighty":25.39607,"marketCap":99382911625},{"date":"2024-09-27","current":-15.534788,"twenty":-24.197578,"median":14.814975,"eighty":25.39607,"marketCap":101613046321},{"date":"2024-10-04","current":-16.799391,"twenty":-24.197578,"median":14.814975,"eighty":25.39607,"marketCap":109884818647},{"date":"2024-10-11","current":-16.241478,"twenty":-24.197578,"median":14.814975,"eighty":25.39607,"marketCap":106235507327},{"date":"2024-10-18","current":-16.48324,"twenty":-24.197578,"median":14.814975,"eighty":25.39607,"marketCap":107816875566},{"date":"2024-10-25","current":-16.402653,"twenty":-24.197578,"median":14.814975,"eighty":25.39607,"marketCap":107289752819},{"date":"2024-10-31","current":-16.322065,"twenty":-24.197578,"median":14.812351,"eighty":25.39607,"marketCap":106762630073},{"date":"2024-11-08","current":-15.288171,"twenty":-24.199732,"median":13.697044,"eighty":25.3977,"marketCap":110961545834},{"date":"2024-11-15","current":-16.347249,"twenty":-24.199732,"median":13.400607,"eighty":25.3977,"marketCap":118648335429},{"date":"2024-11-22","current":-16.2718,"twenty":-24.199732,"median":13.207884,"eighty":25.3977,"marketCap":118100727727},{"date":"2024-11-29","current":-16.548446,"twenty":-24.199732,"median":13.07937,"eighty":25.3977,"marketCap":120108622634},{"date":"2024-12-06","current":-16.442259,"twenty":-24.199732,"median":13.01341,"eighty":25.3977,"marketCap":119337915498},{"date":"2024-12-13","current":-15.726892,"twenty":-24.199732,"median":12.968664,"eighty":25.320507,"marketCap":114145783212},{"date":"2024-12-20","current":-15.732481,"twenty":-24.199732,"median":12.88985,"eighty":25.094333,"marketCap":114186346746},{"date":"2024-12-27","current":-16.207529,"twenty":-24.199732,"median":12.836673,"eighty":24.91965,"marketCap":117634247092},{"date":"2025-01-03","current":-15.869407,"twenty":-24.199732,"median":12.825525,"eighty":24.830114,"marketCap":115180153316},{"date":"2025-01-10","current":-15.874995,"twenty":-24.201887,"median":12.736577,"eighty":24.700357,"marketCap":115220716849},{"date":"2025-01-17","current":-15.754836,"twenty":-24.201887,"median":12.665354,"eighty":24.382395,"marketCap":114348600880},{"date":"2025-01-24","current":-16.526091,"twenty":-24.201887,"median":12.629443,"eighty":24.315777,"marketCap":119946368500},{"date":"2025-01-31","current":-16.526091,"twenty":-24.201887,"median":12.589219,"eighty":24.176109,"marketCap":119946368500},{"date":"2025-02-07","current":-16.045454,"twenty":-24.201887,"median":12.557292,"eighty":24.139507,"marketCap":116457904621},{"date":"2025-02-14","current":-12.693406,"twenty":-24.201887,"median":12.48999,"eighty":24.058649,"marketCap":113580593927},{"date":"2025-02-21","current":-12.652584,"twenty":-24.201887,"median":12.441862,"eighty":24.03394,"marketCap":113215317763},{"date":"2025-02-28","current":-13.33522,"twenty":-24.201887,"median":12.405023,"eighty":23.957965,"marketCap":119323546952},{"date":"2025-03-07","current":-13.648189,"twenty":-24.204041,"median":12.35322,"eighty":23.91379,"marketCap":122123997544},{"date":"2025-03-14","current":-13.670868,"twenty":-24.204041,"median":12.333293,"eighty":23.792996,"marketCap":122326928746},{"date":"2025-03-21","current":-13.702619,"twenty":-24.204041,"median":12.308013,"eighty":23.674229,"marketCap":122611032429},{"date":"2025-03-28","current":-13.357899,"twenty":-24.204041,"median":12.274857,"eighty":23.602452,"marketCap":119526478154},{"date":"2025-04-04","current":-13.14819,"twenty":-24.204041,"median":12.234334,"eighty":23.545063,"marketCap":117650007992},{"date":"2025-04-11","current":-11.474536,"twenty":-24.201887,"median":12.193385,"eighty":23.482347,"marketCap":102674150870},{"date":"2025-04-17","current":-11.224398,"twenty":-24.201887,"median":12.165443,"eighty":23.454761,"marketCap":100435911354},{"date":"2025-04-22","current":-11.12889,"twenty":-24.204041,"median":12.10488,"eighty":23.409797,"marketCap":99581310812}],"updateTime":1745402259275}}}